Trans-Activators

"Trans-Activators" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins.

Descriptor ID	D015534
MeSH Number(s)	D12.776.260.755 D12.776.930.900 D12.776.964.925.984
Concept/Terms	Trans-Activators Trans-Activators Trans Activators Transactivators Trans-Activator Trans Activator Transactivator Trans-Acting Factor Factor, Trans-Acting Trans Acting Factor Trans-Acting Factors Factors, Trans-Acting Trans Acting Factors Nuclear Trans-Acting Factor Nuclear Trans-Acting Factor Factor, Nuclear Trans-Acting Nuclear Trans Acting Factor Trans-Acting Factor, Nuclear

Below are MeSH descriptors whose meaning is more general than "Trans-Activators".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
DNA-Binding Proteins [D12.776.260]
Trans-Activators [D12.776.260.755]
Transcription Factors [D12.776.930]
Trans-Activators [D12.776.930.900]
Viral Proteins [D12.776.964]
Viral Regulatory and Accessory Proteins [D12.776.964.925]
Trans-Activators [D12.776.964.925.984]

Below are MeSH descriptors whose meaning is related to "Trans-Activators".

Below are MeSH descriptors whose meaning is more specific than "Trans-Activators".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Trans-Activators" by people in this website by year, and whether "Trans-Activators" was a major or minor topic of these publications.

Bar chart showing 231 publications over 29 distinct years, with a maximum of 23 publications in 2004

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	1	2
1996	4	0	4
1997	6	2	8
1998	5	3	8
1999	10	1	11
2000	6	4	10
2001	4	5	9
2002	11	6	17
2003	6	15	21
2004	11	12	23
2005	12	10	22
2006	6	4	10
2007	9	2	11
2008	3	4	7
2009	3	7	10
2010	3	2	5
2011	3	3	6
2012	4	3	7
2013	4	3	7
2014	2	0	2
2015	1	6	7
2016	1	1	2
2017	2	1	3
2018	3	4	7
2019	3	1	4
2020	3	0	3
2021	2	1	3
2022	0	1	1
2024	0	1	1

Below are the most recent publications written about "Trans-Activators" by people in Profiles.

Goel HL, Karner ER, Kumar A, Mukhopadhyay D, Goel S, Mercurio AM. YAP/TAZ-mediated regulation of laminin 332 is enabled by ?4 integrin repression of ZEB1 to promote ferroptosis resistance. J Biol Chem. 2024 Apr; 300(4):107202.

View in: PubMed
Mia MM, Cibi DM, Ghani SABA, Singh A, Tee N, Sivakumar V, Bogireddi H, Cook SA, Mao J, Singh MK. Loss of Yap/Taz in cardiac fibroblasts attenuates adverse remodelling and improves cardiac function. Cardiovasc Res. 2022 06 22; 118(7):1785-1804.

View in: PubMed
Kiritsy MC, Ankley LM, Trombley J, Huizinga GP, Lord AE, Orning P, Elling R, Fitzgerald KA, Olive AJ. A genetic screen in macrophages identifies new regulators of IFN?-inducible MHCII that contribute to T cell activation. Elife. 2021 11 08; 10.

View in: PubMed
van der Kouwe E, Heller G, Czibere A, Pulikkan JA, Agreiter C, Castilla LH, Delwel R, Di Ruscio A, Ebralidze AK, Forte M, Grebien F, Heyes E, Kazianka L, Klinger J, Kornauth C, Le T, Lind K, Barbosa IAM, Pemovska T, Pichler A, Schmolke AS, Schweicker CM, Sill H, Sperr WR, Spittler A, Surapally S, Trinh BQ, Valent P, Vanura K, Welner RS, Zuber J, Tenen DG, Staber PB. Core-binding factor leukemia hijacks the T-cell-prone PU.1 antisense promoter. Blood. 2021 10 14; 138(15):1345-1358.

View in: PubMed
Forlani G, Michaux J, Pak H, Huber F, Marie Joseph EL, Ramia E, Stevenson BJ, Linnebacher M, Accolla RS, Bassani-Sternberg M. CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens. Mol Cell Proteomics. 2021; 20:100032.

View in: PubMed
Mia MM, Cibi DM, Abdul Ghani SAB, Song W, Tee N, Ghosh S, Mao J, Olson EN, Singh MK. YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction. PLoS Biol. 2020 12; 18(12):e3000941.

View in: PubMed
Bernard H, Teijeiro A, Chaves-P?rez A, Perna C, Satish B, Novials A, Wang JP, Djouder N. Coxsackievirus B Type 4 Infection in ? Cells Downregulates the Chaperone Prefoldin URI to Induce a MODY4-like Diabetes via Pdx1 Silencing. Cell Rep Med. 2020 10 20; 1(7):100125.

View in: PubMed
Chen HJ, Li Q, Nirala NK, Ip YT. The Snakeskin-Mesh Complex of Smooth Septate Junction Restricts Yorkie to Regulate Intestinal Homeostasis in Drosophila. Stem Cell Reports. 2020 05 12; 14(5):828-844.

View in: PubMed
Li H, Li Q, Dang K, Ma S, Cotton JL, Yang S, Zhu LJ, Deng AC, Ip YT, Johnson RL, Wu X, Punzo C, Mao J. YAP/TAZ Activation Drives Uveal Melanoma Initiation and Progression. Cell Rep. 2019 12 03; 29(10):3200-3211.e4.

View in: PubMed
Kamga L, Gil A, Song I, Brody R, Ghersi D, Aslan N, Stern LJ, Selin LK, Luzuriaga K. CDR3a?drives selection of the immunodominant Epstein Barr virus (EBV) BRLF1-specific CD8 T cell receptor repertoire in primary infection. PLoS Pathog. 2019 11; 15(11):e1008122.

View in: PubMed